Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study

NCT06078722 · clinicaltrials.gov ↗

UNKNOWN

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Metabolic-associated Fatty Liver Disease (MAFLD)

Sponsor

Kazakh Association of Internal Medicine Specialists